BioSpace News Archive

Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, will report results for the first quarter ended March 31, 2021, after the market closes on April 28, 2021. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on April 29, 2021.

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

The Clinical and Laboratory Standards Institute has published M100—Performance Standards for Antimicrobial Susceptibility Testing, 31st Edition.

Cloud DX Inc. is pleased to announce the commencement of trading on Thursday April 15th, 2021, on TSX Venture Exchange under the ticker symbol CDX.

The United States House of Representatives passed the Food Allergy Safety, Treatment, Education and Research Act, a critical piece of legislation requiring that sesame be labeled on packaged foods and prioritizing food allergy research.

Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the global phase III clinical trial (BURAN) at Shanghai Eastern Hospital Medical Center in China.

Effectiveness in reducing inflammation, sneezing, and edema is propelling OTC cough cold and allergy medicines sales

OTC vitamins and dietary supplements manufacturers are pushing for new flavor and nutrient formulations to bolster appeal among a wider demographic for product offerings.

The biologics contract manufacturing market may bring immense growth across the forecast period of 2020-2030 on the back of the growing need of professionals in biologics and an increase in the inking of agreements between pharmaceutical companies and biologics contract manufacturing organizations.

The dental veneers market may gain substantial growth across the forecast period of 2020-2030 owing to the growing global demand for the veneers.